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Background: Persistent organic pollutants (POPs) are hazardous chemicals omnipresent in our food chain, which
have been internationally regulated to ensure public health. Initially described for their potency to affect
reproduction and promote cancer, recent studies have highlighted an unexpected implication of POPs in the
development of metabolic diseases like type 2 diabetes and obesity. Based on this novel knowledge, this article
aims at stimulating discussion and evaluating the effectiveness of current POP legislation to protect humans against
the risk of metabolic diseases. Furthermore, the regulation of POPs in animal food products in the European Union
(EU) is addressed, with a special focus on marine food since it may represent a major source of POP exposure to
humans.
Discussion: There is mounting scientific evidence showing that current POP risk assessment and regulation cannot
effectively protect humans against metabolic disorders. Better regulatory control of POPs in dietary products should
be of high public health priority.
Summary: The general population is exposed to sufficient POPs, both in term of concentration and diversity, to
induce metabolic disorders. This situation should attract the greatest attention from the public health and
governmental authorities.Background
The incidence of obesity and diabetes has dramatically
increased worldwide. From 1980 to 2008, the global
prevalence of obesity has doubled in both men and
women [1], whereas the number of people with diabetes
increased from 153 million in 1980 to 347 million in
2008 [2]. A recent report realised in the European Union
(EU) highlights that overweight and obesity affect more
than 50% of the adult population whereas diabetes is
now affecting over 30 million people [3]. In the United
States (US), the prevalence of obesity among children
and adolescents has almost tripled since 1980 [4], and
12% of children aged 2 through 5 years were obese in
2009-2010 [5]. In addition to enhancing the risk of pre-
mature death, diabetes and obesity are major causes of
multiple complications, including hypertension, cardio-
vascular diseases, asthma, blindness, limb amputation,Correspondence: jerome.ruzzin@bio.uib.no
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reproduction in any medium, provided the orand sleep apnea, that generate enormous economic costs
for both health care and loss of productivity to society.
Total annual economic cost of diabetes in the US
reached $132 billion in 2002, representing around 11%
of the US health care expenditure, and increased to $174
billion in 2007 [6,7]. In Europe, obesity-related health-
care was estimated to reach up to 10.4 billion Euros [8].
Although they are the focus of intense investigations,
the origins of metabolic diseases have remained poorly
understood. While there is certainly genetic predispos-
ition, the rapid and explosive incidence of obesity and
type 2 diabetes cannot be due to genetic modifications
in the population. Indeed, the propagation of these dis-
eases is simply too fast to lie at the feet of genetic
changes. Rather, environmental factors like physical in-
activity and consumption of high-energy diets are likely
to be important contributors. However, the view that
these two conventional risk factors alone are the primary
variables explaining the epidemic of metabolic diseases
is being challenged as far too simplistic [9-12].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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furans, polychlorinated biphenyls (PCBs), and organochlor-
ine pesticides, are chemicals mainly created by industrial
activities, either intentionally or as by-products [13]. Be-
cause of their ability to resist environmental degradation,
these substances are omnipresent in food products, and
found all around the world, even in areas where they have
never been used like Antarctica [14]. Thus, virtually all
humans are daily exposed to POPs. In the general popula-
tion, exposure to POPs comes primarily from the con-
sumption of animal fat like fatty fish, meat and milk
products; the highest POP concentrations being commonly
found in fatty fish [15-26].
POPs are lipophilic chemicals that can pass through bio-
logical phospholipid membranes and bio-accumulate in
fatty rich tissues of humans. Initially described for their
deleterious effects on reproductive function and carcino-
genicity, there is now growing body of evidence showing
that exposure to POPs leads to metabolic diseases. First,
many epidemiological studies performed in the US, Europe
and Asia have led to the common finding that there is an
increased body burden of POPs in people with diabetes
[27-39]. For instance, diabetes has been associated with ele-
vated serum levels of 2,3,7,8-tetrachlorodibenzodioxin
(TCDD), 2,2',4,4',5,5'-hexachlorobiphenyl (CB153), coplanar
polychlorinated biphenyls (PCBs; CB77, CB81, CB126,
CB169), p,p'-diphenyldichloroethene (DDE), oxychlordane
and trans-nonachlor. In addition, bio-accumulation of
PCBs has been linked to non-alcoholic fatty liver disease
(NAFLD) and elevated blood pressure [40,41]. Recently,
prospective studies have furthermore shown an increased
risk of diabetes in persons exposed to POPs, especially or-
ganochlorine pesticides [39,42,43]. Second, there is evidence
for a causal relationship between POP exposure and meta-
bolic disorders linked to insulin resistance. Animals
exposed to environmental levels of POP mixtures through
the intake of non-decontaminated fish oil (obtained from
farmed Atlantic salmon) exhibited insulin resistance, glu-
cose intolerance, abdominal obesity and NAFLD [44]. In
rats fed decontaminated crude salmon oil, which contained
very low levels of POPs, these metabolic disturbances were
almost absent. Importantly, the body burden of POPs in
rats exposed to non-decontaminated salmon oil did not ex-
ceed those observed in humans 40-50 years of age, thereby
underlying that the animals were not over-exposed to POPs
[44]. Further, the presence of POPs in farmed Atlantic sal-
mon fillet was found to accelerate the development of vis-
ceral obesity and insulin resistance in mice [45]. Other
studies exposing rodent to single POP compound reported
metabolic dysfunctions like NAFLD or increased body
weight gain [46,47]. Third, in vitro investigations showed
that POPs are powerful disruptors of metabolic homeostasis
[44-46,48], which is consistent with the obesogen properties
of some xenobiotics [49]. Taken together, these findingsobserved in humans, animals, and cell models, demonstrate
that POPs are potent environmental contributors to meta-
bolic diseases. Based on this novel knowledge, the present
article aims to stimulate discussion and to evaluate the ef-
fectiveness of current POP legislation to protect humans
against the risk of metabolic diseases.
Discussion
Current regulation and risk assessment of POPs
To protect humans, the United Nations Environment
Programme (UNEP), in 1997, issued an international action
to reduce the global release of 12 POPs, the “dirty dozen”,
which included nine organochlorinated pesticides; aldrin,
chlordane, dichlorodiphenyltrichloroethane (DDT), dieldrin,
endrin, heptachlor, hexachlorobenzene, mirex, toxaphene,
and three industrial chemicals; dioxins, furans, and PCBs. In
2001, the Stockholm Convention on POPs was ratified by
151 signatories, and the Convention entered into force three
years later [50].
Aldrin, chlordane, DDT, dieldrin, endrin, heptachlor,
mirex, and toxaphene were extensively used in agriculture
as insecticides, whereas hexachlorobenzene was used as a
fungicide. By 1990, these POPs were prohibited for use on
crops and termite control by most European and North
American countries because of their potential threat to
human health [51]. DDT has also been utilized in indoor
spraying for control of vectors of malaria, dengue, visceral
leishmaniasis, and Chagas disease, and its use for the pur-
pose of controlling disease vectors has been permitted by
the Stockholm Convention, in accordance with recommen-
dations and guidelines of the World Health Organization
(WHO) [52]. In its Position Statement, WHO stipulates that
a sudden ban on DDT use could have significant conse-
quences for the burden of malaria because of the absence of
equally effective and efficient alternatives [52]. The use of
DDT in malaria prevention has led to intense debates be-
cause it can save many lives but DDT may, at the same
time, induce adverse human health effects [53-55]. In 2005,
the global production of DDT used for disease vector con-
trol was estimated to reach 5,000 metric tons [56]. Up to
160 metric tons of DDT were still produced for agriculture
purposes [56], and the production of other organochlorine
pesticides, like aldrin and dieldrin, is suspected to occur in
different countries [51]. Not surprisingly, a recent US moni-
toring study revealed that DDT and its metabolites as well
as endosulfan and aldrin, are still largely present in food,
and daily consumed by humans [19].
The term “dioxins” is commonly used to refer a group of
75 polychlorinated dibenzo-p-dioxins (PCDDs) and 135
polychlorinated dibenzofurans (PCDFs) congeners among
which less than 20 are believed to be toxic. Dioxin like-
PCBs (dl-PCBs) refer to 12 non-ortho or mono-ortho PCBs
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expert committee, set up by the WHO, developed the con-
cept of toxic equivalent factors (TEF) to facilitate risk as-
sessment and regulatory control of exposure to mixtures of
PCDDs, PCDFs, and dl-PCBs [57]. TEF is based on in vitro
and in vivo data showing that PCDD, PCDF and dl-PCB
congeners induce similar toxic responses to those caused
by TCDD, which is considered as the most potent toxic
congener [57,58]. Thus, TEF is an order of magnitude esti-
mate of the toxicity of a compound relative to TCDD. The
criterion to apply a TEF to a POP congener is the
following:
1) The chemical must show a structural relationship to
PCDDs and PCDFs.
2) The chemical must bind the aryl hydrocarbon
receptor (AhR) and elicit AhR-mediated biochemical
and toxic responses.
3) The chemical must be ubiquitous in the food chain.
To further estimate the toxicity of POP mixtures to
which humans and organisms can be exposed, TEF values
are used to calculate toxic equivalent (TEQ) concentrations
as follows: TEQ = Σn1 (PCDDsi × TEFi) + Σn2 (PCDFsi ×
TEFi) + Σn3 (dl-PCBsi × TEFi). This approach assumes that
the combined effects of different PCDD, PCDF and dl-PCB
congeners produce additive toxic effects.
The Stockholm Convention has led to substantial reduc-
tion of POP production. Dietary surveys have reported that
the concentrations of organochlorine pesticides, dioxins,
and PCBs have declined in most food products [20,59,60].
Furthermore, many studies characterizing the temporal
trends of these classical POPs in human blood showed that
the concentrations of these pollutants have decreased dur-
ing the last years [61-64], although the human body burden
of so-called “emerging” POPs, like polybrominated diphenyl
ether (PBDE) and some perfluorinated compounds, have
remained stable or even increased [65-67]. The present situ-
ation may therefore indicate that the current background
exposure to POPs is still sufficient to perturb hormonal and
metabolic homeostasis of the human body.
In general, safety guidelines have been performed by iden-
tifying the most sensitive effects of single POP, and has
mainly focused on TCDD and its impacts on immunotoxi-
city, carcinogenotoxicity, reproductive and developmental
toxicity in animals. In 2000, the Scientific Committee on
Food (SCF) of the European Commission reviewed extensive
data and experimental results and recommended a tolerable
weekly intake (TWI) of 7 pg WHO-TEQ/kg body weight to
protect consumers from the harmful effects associated with
environmental contaminant exposure through consumption
of food products [68]. Only six months later, the SCF re-
assessed the TWI by focusing on non-carcinogenetic end-
points only [69], and increased the TWI from 7 to 14 pgWHO-TEQ/kg body weight based on rat studies investigat-
ing the reproductive effects of male offspring [70]. Below this
level, contaminants are expected to have no effects or its
effects are reversed by body’s defence mechanisms. Today,
various authorities have defined their own maximum daily
exposure limits, tolerable daily intake (TDI), within the range
of 1 to 4 pg WHO-TEQ/kg body weight/day. Still, although
some population has TDI below national ranges, many stud-
ies have documented that exposure to dioxins and dl-PCBs
to humans, especially children, can be above the recom-
mended TDI levels [15,21,23,24,59,71,72].
Main limitations of current risk assessment on POPs in
relation with metabolic disorders
1) TEQ and the concept of additive toxic effects.
Although TEQ concept is based on additive effects
of pollutants, i.e. high doses of a chemical are
expected to cause greater deleterious effects than
low doses, not all studies on environmental
pollutants and xenobiotics support this concept
[42,73-77]. Accumulating data continue to underline
the existence of a non-linear or inverted relationship
between environmental pollutants and their
detrimental effects; strong biological effects in low
dose of exposure but weak or no effects in higher
dose. For instance, exposure to low concentrations
of TCDD and 1,2,3,4,7,8-hexachlorodibenzo-p-
dioxin (HxCDD) increased body weight gain in rats
whereas at higher doses of exposure, both TCDD
and HxCDD decreased body weight [46].
Consistently, low doses of CB-77 and TCDD were
found to promote adipocyte differentiation whereas
higher doses resulted in the absence of cell
differentiation [48]. Furthermore, 3T3-L1 adipocytes
incubated with low concentration of CB-77
stimulated adipokine release whereas this effect was
absent when cells were exposed to high CB-77
concentration. Overall, the assumption that the
combined effects of different congeners are dose-
additive, which is the most important prerequisite of
the TEQ concept, is highly questionable and linear
extrapolation procedure is likely to under-estimate
the metabolic risks linked to POP exposure.
2) TEF, TEQ and the assumption that dioxins and dl-
PCBs exhibit similar types of biological effects
through interaction with AhR. TEF concept assumes
that, among POPs, TCDD is the most toxic
chemical. Therefore, the potency of dioxins, furans
and dl-PCBs has been expressed as fractions of the
potency of TCDD. Although TCDD, through AhR
activation, may induce cancer, reproduction and
neuronal dysfunctions, TEQ is unlikely to predict
the risk of metabolic disorders induced by POP
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mixtures to impair insulin action in 3T3L1
adipocytes was reported to be independent of TEQ
(Figure 1). Both PCDD and PCDF mixtures did not
impair insulin-stimulated glucose uptake compared
with vehicle-treated cells, whereas non- and mono-
ortho-PCB mixtures induced significant disruption
of insulin action (Figure 1). Interestingly, the
stimulation of glucose uptake induced by insulin was
highly impaired after exposure to mixtures of
organochlorine pesticides. These in vitro findings are
consistent with many human studies indicating that
POPs increase the risk of diabetes independently of
TEQ, and that some organochlorine pesticides, like
trans-nonachlor, are more strongly associated with
diabetes than other POPs [29,42,78]. Consistently,
in vitro experiments using single POP compound
reported that, at similar TEQ value, CB-77
stimulated adipocyte differentiation whereas this
effect was absent in cells treated with TCDD [48]. In
concert, these results suggest that the deleterious
metabolic effects associated with POP exposure may
occur independently of AhR activation. Potential
modes of action of POPs may include activation of
constitutive androstane receptor (CAR) or steroid
xenobiotic receptor (SXR), and competitive binding
to nuclear receptors [79,80].R
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Figure 1 Effect of POP mixtures on insulin action. Differentiated
3T3-L1 adipoctytes were incubated for 48 h with different POP
mixtures mimicking those present in the oil of farmed Atlantic
salmon. The ability of insulin (30nM) to stimulate glucose uptake
was assessed. Note that the PCDF mixture and its elevated TEQ
value did not impair insulin-stimulated glucose uptake. At the
opposite, PCB mixtures and their low TEQ values significantly
impaired insulin action. The most important inhibitory effect on
insulin action was observed after exposure to organochlorine
pesticides (1nM). PCDDs, polychlorinated dibenzo-p-dioxins; PCDFs,
polychlorinated dibenzofurans; PCBs, polychlorinated biphenyls; OPs,
organochlorine pesticides. Data are expressed as relative glucose
uptake and presented as mean ± SEM. *p < 0.05; Data are adapted
from [44].3) Adult and early life exposure. There is a special
concern regarding children because regulatory
policies, which established dioxins and dl-PCBs
tolerable intake on a body weight basis, do not
distinguish between children and adults. Because of
their high food intake per kilogram body weight
required to maintain whole-body homeostasis and
growth, children are likely to be at higher risk for
environmental pollutant exposure. Not surprisingly,
many scientific studies have highlighted that
children are over-exposed to dioxins and dl-PCBs,
and exceed the TDI of 2 pg/kg body weight
[15,21,23,81-87]. Furthermore, both metabolism,
absorption and excretion system are different in
children compared with adults, so that this
subpopulation may potentially be more responsive to
environmental pollutants [88]. Another important
issue concerns foetal life. Generally, pregnant
women have been advised to avoid the consumption
of food containing elevated levels of POPs, as well as
other environmental pollutants like heavy metals.
However, POPs bio-accumulate in the body for
many years, and restricting the exposure to these
pollutants only during pregnancy would not protect
the foetus or the future generations against the
harmful effects of these hazardous chemicals [89].Inconsistency of POP regulation in animal food products:
the case of marine food
The omnipresence of POPs in animal food products has
led international and national authorities to set up max-
imum limits. In this regard, marine food has attracted
great interest and has been the source of intense debates
[90-92]. In the EU, maximum limit of dioxins, furans
and dl-PCBs in fish and seafood products have been set
to 8 pg WHO 1998 TEQ/g fresh weight [93]. Giving that
these POPs are highly lipophilic and therefore mainly
present in the fat fraction of fish, this concentration
could reach around 70 pg WHO 1998 TEQ/g fat for a
fatty fish (Table 1). On the other hand, the maximum
limit of dioxins, furans and dl-PCBs in marine oil has
been set to 10 pg WHO 1998 TEQ/g fat, a level that is
seven times lower the one possibly observed in muscle
meat of fatty fish. Thus, eating 1 g of fat from a fatty fish
fillet could induce an exposure to 70 pg WHO 1998
TEQ (depending on the fat content of fish), whereas
consuming 1 g of fat from a marine oil product could
lead to an exposure to 10 pg WHO 1998 TEQ. Since the
maximum levels for dioxins and dl-PCBs in foodstuffs
should be set according to their potential harmful effects
and risk to public health, one would expect these levels
to be harmoniously regulated within food products.
Table 1 Regulation of dioxins, furans and dl-PCBs in fish
and other animal food products by the EU
Maximum levels of dioxins, furans and
dl-PCBs (WHO 1998 TEQ)
Meat and meat
products from:
Ruminants: 4.5 pg/g fat
Poultry and
farmed game:
4.0 pg/g fat
Pigs: 1.5 pg/g fat
Muscle meat of
fish and
fishery products1:
8.0 pg/g fresh weight (70.0 pg/g fat)2
Fat products from:
Ruminants: 4.5 pg/g fat
Poultry and farmed game: 4.0 pg/g fat
Pigs: 1.5 pg/g fat
Marine oils: 10.0 pg/g fat
1except eel. 2assuming a fish fillet containing 12% fat like farmed Atlantic
salmon.
Note that the maximum limits of POPs in ruminants, poultry and farmed
game, and pigs are similar in the “Meat and meat products from” compared
with “Fat products from”. In contrast, “Muscle meat of fish and fishery
products” could contain up to 70 pg WHO 1998 TEQ/g fat, which is around
seven times higher the maximum limit set in “Fat products from marine oils”
(10 pg WHO 1998 TEQ/g fat). Adapted from [93].
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chlorine pesticides, which are chemicals strongly linked
to type 2 diabetes [29,32,33,37,44,45] as well as breast
and prostate cancer [94] and Parkinson disease [95]. As
for dioxins, furans and dl-PCBs, the EU has set up max-
imum residue levels in or on food and feed of plant and
animal origin [96]. Thus, fruits, vegetables, products of
terrestrial animal origin, cereals, and other food items
are regulated for their content in pesticides. However,
levels of pesticides are still unregulated in fish and sea-
food in the EU. Similarly, there are still no maximum
limits for PCBs in marine food. Because seafood repre-
sents one of the main sources of human exposure to
POPs, and that POPs contribute to metabolic diseases,
policy makers and stakeholders should urgently regulate
and diminish the concentrations of POPs in seafood to
protect the general population. Indeed, recent studies
have reported an association between fish and seafood
intake and type 2 diabetes in humans [97-99], and pos-
sible connection between farmed Atlantic salmon and
the epidemic of type 2 diabetes has been suggested
[100].
Further, some EU countries, like Finland and Sweden,
have obtained dispensations to sell fish species from the
Baltic sea, a highly polluted area where fish species can ac-
cumulate significant levels of POPs -dioxin levels higherthan 4 pg/g fresh weight of muscle meat and fishery pro-
ducts are allowed [93]. Also, the maximum levels of dioxins
and dl-PCBs in muscle meat of eel, a potential highly con-
taminated fish, reached 12 pg WHO 1998 TEQ/g fresh
weight, in contrast to the 8 pg WHO 1998 TEQ/g fresh
weight of other fish species [93]. Such derogations likely
rose from the fact that background contamination of cer-
tain foodstuffs is already very high -mainly because of
human pollution- and that keeping maximum dioxins and
dl-PCBs levels similar in all food products would result to
declare considerable part of our present food supply unfit
for human consumption [68]. Unfortunately, this strategy is
not aimed to reduce human exposure to POPs and raise
serious questions about the effectiveness of EU regulations
to protect consumers.
Summary
The global prevalence of metabolic diseases like obesity and
type 2 diabetes, and its colossal economic and social costs
represent a major public health issue for our societies. There
is now solid evidence demonstrating the contribution of
POPs, at environmental levels, to metabolic disorders. Thus,
human exposure to POPs might have, for decades, been suf-
ficient and enough to participate to the epidemics of obesity
and type 2 diabetes. Based on recent studies, the funda-
ments of current risk assessment of POPs, like “concept of
additive effects” or “dioxins and dl-PCBs induced similar
biological effects through AhR”, appear unlikely to predict
the risk of metabolic diseases. Furthermore, POP regulation
in food products should be harmonized and re-evaluated to
better protect consumers. Neglecting the novel and emer-
ging knowledge about the link between POPs and metabolic
diseases will have significant health impacts for the general
population and the next generations.
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